American Society of Clinical Oncology (ASCO): an opportunity to present our oncology’s portfolio. Report 31 May- 4 June 2019, Chicago
The ASCO 2019 took place in Chicago from this Friday 31 May until Tuesday 4 June.
This 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) gathered cancer experts from around the world to share the latest advances in clinical cancer research. The theme of this year’s conference was “Caring for Every Patient, Learning From Every Patient”.
This congress was an essential platform for scientific exchange and networking with invaluable contributions from experts from around the world. WeHealth Digital Medicine was present during the congress with a booth in order to present the latest news about its Innovative Digital Solutions Portfolio.
WeHealth Digital Medicine Booth:
WeHealth’s booth was an opportunity to present for the first time our oncology’s portfolio with two solutions, ready for launch: OCELIAN™ and BIONOV™. Our collaborative team composed of WeHealth and our start-up partners from US (CureMATCH) and France (DeepLink Medical) welcomed scientists and physicians from all around the world.
More than 500 attendees visited our booth, 200 oncologists from well-known institutions, CRO or Biotechs from US, France, Italy, Germany, Australia, Japan, etc…had a live demo of these two innovations.
Scientists had questions about the availability of this two products and their accessibility for their patients and showed a great interest about this two products.